All Episodes

July 21, 2025 9 mins

Welcome to another episode of 'Diabetic Foot Files', where Dr. G delves into the unconventional yet promising world of cryotherapy as a potential treatment for diabetic foot ulcers. Discover how extreme cold, typically reserved for dermatology and oncology, is being re-evaluated for its efficacy in wound care.

This episode takes a close look at how cryotherapy—through both topical cryospray and cryoablation methods—can precisely target and eliminate necrotic tissue, reduce inflammation, and stimulate healing in stubborn ulcers. Despite its rare usage in diabetic wound care so far, early research suggests that cryotherapy could offer a minimally invasive, cost-effective alternative to traditional treatments for non-healing ulcers.

With potential benefits such as painless tissue removal and reduced systemic side effects, cryotherapy represents an innovative "reset button" for chronic wounds. However, the method comes with its own set of risks, including potential cold injury and the need for precise application by trained professionals.

Join Dr. G as he advocates for open-mindedness and curiosity among clinicians and patients alike, urging them to consider every feasible option in the fight against diabetic limb loss. Always remember, innovation in medical care can take many forms, and sometimes, the simplest solutions have been right under our noses—or our feet—all along.

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
24/7 News: The Latest

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.